All In MedTech

Device Trial Radar · NCT00148954

RIGHT: Rhythm ID Going Head-to-Head Trial

Rhythm ID Going Head-to-head Trial

Last checked: Nov 20, 2026Latest source record: Jan 12, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 1,962 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,962

Actual

Start

Jul 2005

Primary completion

Mar 2009

Study completion Jul 2010

Sponsor

Lead sponsor
Boston Scientific CorporationPublic (BSX)
Sponsor type
Industry
First posted
Sep 8, 2005

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RIGHT is a randomized, prospective, two-arm study that will assess the differential efficacy of VITALITY 2 implantable cardioverter defibrillators (ICDs) using Rhythm ID™ versus selected Medtronic ICDs.

Conditions

  • Tachycardia

Interventions

  • VITALITY 2 Implantable Cardioverter DefibrillatorDevice

    VITALITY 2 ICD

  • Medtronic Implantable Cardioverter DefibrillatorDevice

    Maximo, Marquis, Intrinsic, Virtuoso, or Entrust ICD

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Patients With Inappropriate Ventricular Tachycardia (VT)/Ventricular Fibrillation (VF) Therapy (Shock or Antitachycardia Pacing [ATP]) After the Pre-Discharge VisitTime frame: From date of pre-discharge until a minimum of 12 months follow-up until study closure

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Medical University of South Carolina

    Charleston, South Carolina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.